Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -29,198 | -16,178 | -43,799 | -28,032 | -21,606 |
| Depreciation Amortization | 1,166 | 592 | 1,172 | 843 | 576 |
| Other Working Capital | -1,095 | -538 | 1,529 | 1,249 | 499 |
| Other Operating Activity | 3,003 | 2,082 | 7,447 | 3,394 | 2,483 |
| Operating Cash Flow | $-26,124 | $-14,043 | $-33,650 | $-22,546 | $-18,049 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -347 | -253 | -369 | -331 | -222 |
| Investing Cash Flow | $-347 | $-253 | $-369 | $-331 | $-222 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 776 | 784 | 1,649 | 617 | 496 |
| Common Stock Issued | 184 | 81 | 100,457 | 98,777 | 27 |
| Other Financing Activity | -642 | -323 | 0 | 0 | 0 |
| Financing Cash Flow | $318 | $542 | $102,106 | $99,395 | $524 |
| Exchange Rate Effect | 171 | 693 | -202 | -224 | -298 |
| Beginning Cash Position | 118,672 | 119,918 | 56,805 | 55,925 | 57,363 |
| End Cash Position | 92,690 | 106,856 | 124,690 | 132,218 | 39,318 |
| Net Cash Flow | $-25,982 | $-13,062 | $67,885 | $76,293 | $-18,045 |
| Free Cash Flow | |||||
| Operating Cash Flow | -26,124 | -14,043 | -33,650 | -22,546 | -18,049 |
| Capital Expenditure | -347 | -253 | -369 | -331 | -222 |
| Free Cash Flow | -26,471 | -14,296 | -34,019 | -22,877 | -18,271 |